PSA Kinetics as Prognostic Markers of Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate

PSA Kinetics as Prognostic Markers of Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate

Sofia España,1 Maria Ochoa de Olza,2 Nuria Sala,3 Josep Maria Piulats,2 Ulises Ferrandiz,1 Olatz Etxaniz,1 Lucia Heras,2,4 Oscar Buisan,5 Juan Carlos Pardo,1 Jose F Suarez,6 Pilar Barretina,3 Josep Comet,7 Xavier Garcia del Muro,2 Lauro Sumoy,8 Albert Font1 1Catalan Institute of Oncology,...

Full description

Bibliographic Details
Main Authors: España S, Ochoa de Olza M, Sala N, Piulats JM, Ferrandiz U, Etxaniz O, Heras L, Buisan O, Pardo JC, Suarez JF, Barretina P, Comet J, Garcia del Muro X, Sumoy L, Font A
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:Cancer Management and Research
Subjects:
castration-resistant prostate cancer
abiraterone
psa kinetics
survival
early psa response
Online Access:https://test.dovepress.com/psa-kinetics-as-prognostic-markers-of-overall-survival-in-patients-wit-peer-reviewed-article-CMAR

Internet

https://test.dovepress.com/psa-kinetics-as-prognostic-markers-of-overall-survival-in-patients-wit-peer-reviewed-article-CMAR

Similar Items